T-Cell Depleted, Reduced-Intensity Allogeneic Stem Cell Transplantation From Haploidentical Related Donors For Hematologic Malignancies.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ciclosporin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Fludarabine; Prednisone; Rituximab; Vincristine
- Indications Acute myeloid leukaemia; B-cell prolymphocytic leukaemia; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Chronic myelomonocytic leukaemia; Graft-versus-host disease; Hodgkin's disease; Multiple myeloma; Myelodysplastic syndromes; Myeloproliferative disorders; Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma; T-cell prolymphocytic leukaemia
- Focus Therapeutic Use
- 08 Mar 2012 Biomarkers information updated
- 07 Mar 2012 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 07 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.